StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Alnylam Pharmaceuticals Inc

Enter Symbol or Keywords

EBITDA Deteriorates 433% for Alnylam Pharmaceuticals

Stock Quote: (NasdaqNM:ALNY)

11/12/2009

15.35

+0.16

+1.05%

93,121

EBITDA Deteriorates 433% for Alnylam Pharmaceuticals

Last

Price Change

% Chg

Volume

New York, NY, November 12, 2009-Ebitda News reports that negative EBITDA for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) for its quarter ended September 30, 2009 was $(8,539,000), a 433% deterioration ... read full story

Website Address:	www.alnylam.com
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

07/30/2010

EBITDA for AirTran Reaches Twelve Year High

07/30/2010

EBITDA for Union Pacific Reaches Sixteen Year High

07/30/2010

Fourteen Year High in EBITDA for Mettler-Toledo

07/30/2010

CA's EBITDA Hits Nine Year High

07/30/2010

EBITDA for Intuitive Surgical Reaches Nine Year High

07/30/2010

StockDiagnostics.com Reiterates Omnicom Group's OPS Ranking of "2"

07/30/2010

Four Year Low in Free Cash Flow for Embotelladora Andina

07/30/2010

Two Year High in Free Cash Flow for Janus Capital

07/30/2010

Free Cash Flow Decreases 91% for Coca-Cola FEMSA

07/30/2010

StockDiagnostics.com Reiterates Safeway's OPS Ranking of "2"

Interactive Chart: ALNY

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: ALNY

05/14/2010

Alnylam Pharmaceuticals' EBITDA Deteriorates 82%

05/13/2010

Alnylam Pharmaceuticals Experiencing Revenue Uptrend While its Industry is in a Downtrend

03/15/2010

Alnylam Pharmaceuticals' EBITDA Deteriorates 91%

... more ALNY exclusives

Other News Sources: ALNY

07/28/2010

Alnylam to Webcast Conference Call Discussing Second Quarter 2010 Financial Results

07/19/2010

Alnylam to Webcast Virtual RNAi Roundtable on ALN-TTR for Treatment of Transthyretin-Mediated Amyloidosis

07/07/2010

Alnylam Initiates Dosing in Phase I Clinical Study of ALN-TTR01 in Patients with Transthyretin-Mediated Amyloidosis (ATTR)

... more ALNY news from other sources

Daily Market Updates

07/30/2010

Stocks End July with Strongest Monthly Gains in a Year

Stocks ended flat and closed July with the strongest monthly gains in a year. The markets were volatile throughout the session following mixed economic data earlier. Recovery concerns were renewed after GDP growth slowed in Q2, but Chicago PMI jumped ... read full story